Cargando…
The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
Cancer metabolic reprogramming enhances its malignant behaviors and drug resistance, which is regulated by POU domain transcription factors. This study explored the effect of POU domain class 2 transcription factor 1 (POU2F1) on metabolic reprogramming in colon cancer. The POU2F1 expression was anal...
Autores principales: | Lin, Jinguan, Xia, Longzheng, Oyang, Linda, Liang, Jiaxin, Tan, Shiming, Wu, Nayiyuan, Yi, Pin, Pan, Qing, Rao, Shan, Han, Yaqian, Tang, Yanyan, Su, Min, Luo, Xia, Yang, Yiqing, Chen, Xiaohui, Yang, Lixia, Zhou, Yujuan, Liao, Qianjin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837540/ https://www.ncbi.nlm.nih.gov/pubmed/34997215 http://dx.doi.org/10.1038/s41388-021-02148-y |
Ejemplares similares
-
LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1‐p53/c‐Myc axis
por: Oyang, Linda, et al.
Publicado: (2022) -
The function of prohibitins in mitochondria and the clinical potentials
por: Oyang, Linda, et al.
Publicado: (2022) -
Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9
por: Liang, Jiaxin, et al.
Publicado: (2022) -
The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021) -
Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
por: Xu, Xuemeng, et al.
Publicado: (2023)